These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6714281)

  • 1. Entero-hepatic cycling of methotrexate estimated by use of the D-isomer as a reference marker.
    Hendel J; Brodthagen H
    Eur J Clin Pharmacol; 1984; 26(1):103-7. PubMed ID: 6714281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits after intravenous administration.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):499-513. PubMed ID: 6668556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis.
    Seideman P; Beck O; Eksborg S; Wennberg M
    Br J Clin Pharmacol; 1993 Apr; 35(4):409-12. PubMed ID: 8485020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonlinear renal elimination kinetics of methotrexate due to saturation of renal tubular reabsorption.
    Hendel J; Nyfors A
    Eur J Clin Pharmacol; 1984; 26(1):121-4. PubMed ID: 6714284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of non-renal elimination mechanisms of methotrexate (MTX)].
    Erttmann R; Gkanatsas A
    Monatsschr Kinderheilkd; 1985 Aug; 133(8):516-9. PubMed ID: 3876505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species differences in oral bioavailability of methotrexate between rats and monkeys.
    Kuroda T; Namba K; Torimaru T; Kawashima K; Hayashi M
    Biol Pharm Bull; 2000 Mar; 23(3):334-8. PubMed ID: 10726889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of renal tubular transport of methotrexate by probenecid.
    Bourke RS; Chheda G; Bremer A; Watanabe O; Tower DB
    Cancer Res; 1975 Jan; 35(1):110-6. PubMed ID: 1109785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased intestinal absorption of methotrexate in the rat following repeated oral dosing.
    Sonneveld P; Storm AJ; Nooter K
    Res Commun Chem Pathol Pharmacol; 1985 Apr; 48(1):133-6. PubMed ID: 3992025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose methotrexate kinetics in arthritis.
    Edelman J; Biggs DF; Jamali F; Russell AS
    Clin Pharmacol Ther; 1984 Mar; 35(3):382-6. PubMed ID: 6697645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of low doses of methotrexate in patients with psoriasis over the early period of treatment.
    Chládek J; Martínková J; Simková M; Vanecková J; Koudelková V; Nozicková M
    Eur J Clin Pharmacol; 1998 Feb; 53(6):437-44. PubMed ID: 9551702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of bile salts on the enterohepatic circulation of methotrexate in the unanesthetized rat: inhibition of methotrexate intestinal absorption.
    Said HM; Hollander D
    Cancer Chemother Pharmacol; 1986; 16(2):121-4. PubMed ID: 3948296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.
    Chládek J; Grim J; Martínková J; Simková M; Vanìèková J; Koudelková V; Noièková M
    Br J Clin Pharmacol; 2002 Aug; 54(2):147-56. PubMed ID: 12207634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 May; 49(9):2460-4. PubMed ID: 2706634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The enterohepatic circulation of methotrexate in vivo: inhibition by bile salt.
    Griffin D; Said HM
    Cancer Chemother Pharmacol; 1987; 19(1):40-1. PubMed ID: 3815724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal excretion and pharmacokinetics of methotrexate and 7-hydroxy-methotrexate following a 24-h high dose infusion of methotrexate in children.
    Winograd B; Lippens RJ; Oosterbaan MJ; Dirks MJ; Vree TB; van der Kleijn E
    Eur J Clin Pharmacol; 1986; 30(2):231-8. PubMed ID: 3709652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
    Breithaupt H; Küenzlen E
    Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal clearance of methotrexate in man during high-dose oral and intravenous infusion therapy.
    Christophidis N; Louis WJ; Lucas I; Moon W; Vajda FJ
    Cancer Chemother Pharmacol; 1981; 6(1):59-64. PubMed ID: 7273267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of polysorbate 80 on the absorption and distribution of oral methotrexate (MTX) in mice.
    Azmin MN; Stuart JF; Calman KC; Florence AT
    Cancer Chemother Pharmacol; 1982; 9(3):161-4. PubMed ID: 7160051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior.
    Lena N; Imbert AM; Pignon T; Favre R; Meyer G; Cano JP; Carcassonne Y
    Cancer Chemother Pharmacol; 1984; 12(2):120-4. PubMed ID: 6697425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.